ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
Outgoing123
|
118 |
55K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
118
|
55K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
M & A Activities
|
|
Outgoing123
|
1 |
521 |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1
|
521
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Outgoing123
|
113 |
40K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
113
|
40K
|
1
|
|
ASX - By Stock
|
SWM |
Re:
Why SWM is worth more than $1.50 per share
|
|
Outgoing123
|
298 |
88K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
298
|
88K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
Outgoing123
|
307 |
113K |
0 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
307
|
113K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Outgoing123
|
19K |
6.5M |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19K
|
6.5M
|
4
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Presentation to highlight broader potential of Deoxymabs
|
|
Outgoing123
|
87 |
30K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
87
|
30K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
Outgoing123
|
10 |
4.1K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
10
|
4.1K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Outgoing123
|
19K |
6.5M |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
19K
|
6.5M
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
Outgoing123
|
307 |
113K |
6 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
307
|
113K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Outgoing123
|
690 |
272K |
5 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
690
|
272K
|
5
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
975
|
272K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
975
|
272K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
975
|
272K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
Outgoing123
|
61 |
23K |
2 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
61
|
23K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
0 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
975
|
272K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
IXHL - Reddit Forum
|
|
Outgoing123
|
15 |
6.6K |
4 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
15
|
6.6K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
Outgoing123
|
307 |
113K |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
307
|
113K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Clarion clinics
|
|
Outgoing123
|
43 |
12K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
43
|
12K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
2024 An Eventful Year
|
|
Outgoing123
|
61 |
23K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
61
|
23K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces CEO Departure
|
|
Outgoing123
|
92 |
34K |
1 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
92
|
34K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
Outgoing123
|
177 |
78K |
3 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
177
|
78K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
0 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
975
|
272K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces CEO Departure
|
|
Outgoing123
|
92 |
34K |
2 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
92
|
34K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces CEO Departure
|
|
Outgoing123
|
92 |
34K |
4 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
92
|
34K
|
4
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
975
|
272K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
ALL IT TAKES IS TO BE BOUGHT OUT $$$
|
|
Outgoing123
|
9 |
4.6K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
9
|
4.6K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Shareholder Support and Instructions
|
|
Outgoing123
|
975 |
272K |
0 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
975
|
272K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
XMAS 2024 sp prediction
|
|
Outgoing123
|
148 |
72K |
10 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
148
|
72K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
XMAS 2024 sp prediction
|
|
Outgoing123
|
148 |
72K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
148
|
72K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Announces Positive Results from Phase 1 Study
|
|
Outgoing123
|
52 |
16K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
52
|
16K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
Trading on NASDAQ
|
|
Outgoing123
|
307 |
113K |
1 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
307
|
113K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
Outgoing123
|
62 |
14K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
62
|
14K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
ADC's on the move........
|
|
Outgoing123
|
9 |
2.8K |
0 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|
ASX - By Stock
|
IBX Biotech |
Re:
Consolidation in effect today
|
|
Outgoing123
|
153 |
56K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
153
|
56K
|
2
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Computershare to be Appointed as US Transfer Agent
|
|
Outgoing123
|
140 |
49K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
140
|
49K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Computershare to be Appointed as US Transfer Agent
|
|
Outgoing123
|
140 |
49K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
140
|
49K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Positive in vitro data for CHM 1301 CAR NK cells
|
|
Outgoing123
|
79 |
19K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
79
|
19K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer closing date extended to 30 November 2023
|
|
Outgoing123
|
29 |
9.3K |
8 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
29
|
9.3K
|
8
|
|
ASX - By Stock
|
PAB |
Re:
PAB's AGM
|
|
Outgoing123
|
8 |
2.3K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
Outgoing123
|
74 |
26K |
0 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
74
|
26K
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
Outgoing123
|
74 |
26K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
74
|
26K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Outgoing123
|
324 |
101K |
5 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
324
|
101K
|
5
|
|
ASX - By Stock
|
IBX Biotech |
Re:
Consolidation in effect today
|
|
Outgoing123
|
153 |
56K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
153
|
56K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Suspension from Official Quotation
|
|
Outgoing123
|
25 |
10K |
2 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
25
|
10K
|
2
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Chair's Address and CEO Presentation to 2023 AGM
|
|
Outgoing123
|
74 |
26K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
74
|
26K
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Outgoing123
|
19K |
6.5M |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
19K
|
6.5M
|
0
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Outgoing123
|
19K |
6.5M |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
19K
|
6.5M
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Results of Meeting
|
|
Outgoing123
|
9 |
3.5K |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
9
|
3.5K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Outgoing123
|
324 |
101K |
0 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
324
|
101K
|
0
|
|